Filling the gaps to fight cervical cancer.
Beres
Samantha
S
D000284:Administration, Oral; D052685:Alphapapillomavirus / Q000276:immunology; D001061:Appalachian Region / Q000453:epidemiology; D019496:Cancer Vaccines / Q000008:administration & dosage* / Q000191:economics*; D004334:Drug Administration Schedule; D005260:Female; D006266:Health Education; D006295:Health Resources / Q000191:economics; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D006801:Humans; D008403:Mass Screening / Q000379:methods*; D053918:Papillomavirus Vaccines / Q000008:administration & dosage* / Q000191:economics*; D010349:Patient Compliance; D015995:Prevalence; D012307:Risk Factors; D012309:Risk-Taking; D012725:Sexual Behavior / Q000208:ethnology; D014481:United States / Q000453:epidemiology; D002583:Uterine Cervical Neoplasms / Q000191:economics / Q000208:ethnology / Q000209:etiology / Q000517:prevention & control*; D014626:Vaginal Smears
D019496:Cancer Vaccines; D000068857:Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; D053918:Papillomavirus Vaccines